HCP Behavior Shifts In The Age Of AI—And How The Pharmaceutical Industry Should Respond

In the age of AI, I believe that pharmaceutical companies must earn influence through trust, personalized engagement and ...
MM&M

What does it really take to overcome HCP and DTC marketing silos — and why should we try?

As pharma realizes the value of becoming more patient-centric, aligning HCP and DTC brand marketing to the patient journey becomes pivotal. In this MM+M #TrendTalks session, “What does it really take ...
Forbes

How AI Stands To Shift HCP Marketing In 2026 And Beyond

In the pharmaceutical space, AI isn’t just impacting the clinical trial process. It’s also impacting HCP marketing—how pharmaceutical products reach healthcare professionals. We’re already seeing some ...
MM&M

The fall of pharma’s brand journey and the pivot to HCP workflows

Pharma has poured billions into omnichannel over the past decade. The industry has moved from basic email blasts to AI-driven targeting, smarter personalization and orchestration platforms that rival ...
Nasdaq

HCP Factor-Based Stock Analysis

Below is Validea's guru fundamental report for HASHICORP INC (HCP). Of the 22 guru strategies we follow, HCP rates highest using our P/B Growth Investor model based on the published strategy of Partha ...
Nasdaq

HashiCorp, Inc. (HCP) Hits Fresh High: Is There Still Room to Run?

Have you been paying attention to shares of HashiCorp, Inc. (HCP)? Shares have been on the move with the stock up 1.8% over the past month. The stock hit a new 52-week high of $34.4 in the previous ...